Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

Gideon M. Hirschfield*, Mitchell L. Shiffman, Aliya Gulamhusein, Kris V. Kowdley, John M. Vierling, Cynthia Levy, Andreas E. Kremer, Ehud Zigmond, Pietro Andreone, Stuart C. Gordon, Christopher L. Bowlus, Eric J. Lawitz, Richard J. Aspinall, Daniel S. Pratt, Karina Raikhelson, Maria S. Gonzalez-Huezo, Michael A. Heneghan, Sook Hyang Jeong, Alma L. Ladrón De Guevara, Marlyn J. MayoGeorge N. Dalekos, Joost P.H. Drenth, Ewa Janczewska, Barbara A. Leggett, Frederik Nevens, Victor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Pietro Invernizzi, Palak J. Trivedi, Lisa Forman, David E.J. Jones, Stephen D. Ryder, Mark G. Swain, Alexandra Steinberg, Pol F. Boudes, Yun Jung Choi, Charles A. McWherter, Raul Adrover, Saurabh Agrawal, Elmar Aigner, Agustin A. Martinez, Abu Mouch S. Alden, Raul Jesús Andrade Bellido, Marco Antonio Arrese Jiménez, Walid Ayoub, Seth J. Baum, Ziv Ben-Ari, Marina Berenguer, Christoph Berg, Fernando O. Bessone, Alan Bonder, Brian B. Borg, Carlos Gustavo Bresky Ruiz, Peter Buggisch, Jose Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel-Haggai, Francesca Carubbi, Pilar Castillo Grau, Chin L. Ch'ng, Nicoleta Claudia Cimpoeru, Raúl C. Omaña, Lynsey Corless, Charlotte Costentin, Marc Deschênes, Yvonne Dörffel, Predrag Dugalic, Geoffrey C. Farrell, José L. Fernández, Annarosa Floreani, Sven Francque, Bradley L. Freilich, Francisco Alejandro Fuster Saldias, Michael R. Galambos, Joseph Galati, Andrea Galli, Nathalie Ganne-Carrie, Natalia Geyvandova, Liliana Simona Gheorghe, Richard Gilroy, Aparna Goel, Tobias Goeser, Susan Greenbloom, Waldemar Halota, Stephen A. Harrison, Marek Hartleb, Jeong Heo, Harald Hofer, Gábor Horváth, Jonathan C. Huang, Jason L. Huffman, Béla Hunyady, Steven Johnson, Yiannis Kallis, Arun Khazanchi, Kyung Ah Kim, Seung Up Kim, Yoon Jun Kim, Anita Kohli, Nicholas Kontorinis, John R. Lake, Kwan Sik Lee, Tomasz Mach, Richard Manch, Yaakov Maor-Kendler, Radu Bogdan Mateescu, Gerald Minuk, Apurva A. Modi, Martin W. Moehlen, Cristina M. Rodríguez, Rosa Maria Morillas Cunill, Ioannis Mouzas, Andrew Muir, István Nagy, Jing Hieng (Jeffrey) Ngu, Joseph Odin, Pavel Ogurtsov, Pawel Pabjan, Mangesh Pagadala, Mária Papp, Albert Parés, Andrey Peskov, Adam Peyton, John Phillips, Michael Porayko, Anthony Post, David C. Pound, Mordechai Rabinovitz, Kevin Rank, K. Gautham Reddy, Jaroslaw Regula, Thomas Riley, Manuel R. Gómez, Rifaat Safadi, David A. Sheridan, Marcelo O. Silva, Marina G. Silveira, Siddarth Sood, Ioan Sporea, Carmen Stanca, Rudolf Stauber, Petar Svorcan, Won Young Tak, Ryan M. Taylor, Douglas Thorburn, Hillel Tobias, Arnany T. Zekry, Michael Trauner, Christos Triantos, Ella Veitsman, Alexander James Venn Thompson, Xavier Verhelst, Elizabeth C. Verna, Manfred Von Der Ohe, Frank Weilert, Johannes Wiegand, Kidist K. Yimam, Seung Kew Yoon, Ziad Younes, Adam S. Zivony, Massimo Zuin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences